MedCann’s Pierre Debs to Speak at the Berlin ICBC

MedCann

MedCann founder Pierre Debs has a rather remarkable story about how he rose to the highest ranks of the medical cannabis industry in Germany. The European powerhouse’s medical law has emerged as a progressive beacon that is helping lead the way for the rest of the world in a number of areas, thanks to pioneers like Dr. Debs. I am really looking forward to meeting with Pierre at the International Cannabis Business Conference (ICBC) in Berlin and am appreciative that he could set aside a few minutes to talk with me over Skype about his history with medical cannabis.

Pierre Debs’ tale with cannabis started with a family member’s bout with cancer.  Pierre delved into learning about medical cannabis, including the the human endocannabinoid system and the phytocannabinoids in the plant itself. Debs intensely focused upon his research and science, after leaving the lab in early  2015 he co-founded MedCann to help German patients acquire safe medical cannabis.

“It is fantastic that in Germany insurance companies will cover medical cannabis. What is even more fantastic is that the ruling conservative political party pushed the policy,” Debs told me.

MedCann was the first German company to import dried medical cannabis flowers from Canada, helping add to the momentum for international cooperation that Germany has fostered to implement its medical cannabis system. MedCann has been acquired by Canada’s Canopy Growth recently, and the German operation remains the same, they “just have a different owner.” Germany has recently expanded its medical cannabis program and will soon start licensing domestic production.

As someone born in the states, but living in Germany since 1999,  Pierre has a unique perspective on the medical policies in both Europe and the United States, noting that, “Each country is in its own process. The laws and restrictions in the United States have provided an opportunity for Europe to take the lead on medical cannabis research in many ways. But it hasn’t been easy in Germany, and we are making progress to get where we need to go. And we will. And so will the United States.”

With so much progress recently in Germany, it is easy to see that it is helping lead the way internationally. Hopefully, other nations will soon follow in Germany’s footsteps and cover medical cannabis with healthcare insurance. With researchers and dedicated minds like Pierre Debs forging a path that is normalizing and mainstreaming medicinal cannabis at a rapid pace, the world will be hearing from, and learning from, the German medical cannabis community in the months and years to come.

Join Pierre Debs and other great medical and business minds at the International Cannabis Business Conference in Berlin, Germany, on April 10-12. This is a truly historic event that is expected to sell out, so get your tickets soon

This blog was originally published at www.internationalcbc.com and has been reposted here with special permission. 

Anthony Johnson
About Anthony Johnson 159 Articles
Anthony Johnson, co-owner of Duff Johnson Consulting (DJC), served as the director of New Approach Oregon, the Political Action Committee responsible for Oregon's 2014 Measure 91 cannabis legalization campaign and is currently co-director of the New Revenue Coalition working to legalize cannabis cafes through the Oregon Legislature. Johnson has co-authored state and local measures in multiple states and has assisted several successful political campaigns. DJC clients include the International Cannabis Business Conference, the Oregon Marijuana Business Conference, Natural Roots, Cannabliss, and numerous medical cannabis cultivators that provide free cannabis to patients in need. DJC assists with licensing, reporting, compliance, public relations, and marketinging, among other tasks, for cannabis and ancillary businesses and campaigns.When he and his co-hosts have time, Anthony hosts the Let's Hash It Out podcast, available here on Weed News, at www.letshashitout.blog, Sound Cloud, iTunes, and Stitcher. Anthony's blogs on Weed News are personal and don't necessarily reflect the views of any organization or company.